IBO Impact BioMedical, INC.

Fundamentals / CIK 0001834105 / USD

Impact BioMedical, INC. reported $32K in revenue and net income of $1.61M for the fiscal year ended December 31, 2025, with a -1225.0% gross margin and a -15028.1% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open IBO in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

4 fiscal years (2022 to 2025), reported in USD.

$2.66M$1.33M$0-$23.11MFY 2022 Revenue: $50KFY 2022 Net Income: -$7.25M2022FY 2023 Net Income: -$4.34M2023FY 2024 Net Income: -$24.71M2024FY 2025 Revenue: $32KFY 2025 Net Income: -$11.84M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31
Revenue $32K -- -- $50K
Cost of Revenue $424K -- -- --
Gross Profit -$392K -- -- --
Research & Development $340K $278K $1.69M $1.23M
Selling, General & Admin $873K $718K $315K $325K
Total Operating Expenses -- $28.75M $4.03M --
Operating Income -$4.28M -$28.75M -$4.03M -$3.40M
EBITDA -$3.14M -$27.63M -$2.91M -$2.29M
Interest Income -- -- $13K $24K
Interest Expense $793K $1.06M $444K $462K
Income Before Tax -$14.45M -$24.74M -$4.41M -$7.88M
Income Tax Expense -$2.58M $33K -- -$621K
Net Income -$11.84M -$24.71M -$4.34M -$7.25M
Basic EPS -$4.85 -$29.37 -$0.89 -$1.28
Diluted EPS -$4.85 -$29.37 -$0.89 -$1.28
Basic Shares Outstanding 2.5M 842.3K 4.7M 5.5M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $21K $3.0K $7.0K -- $18K $7.0K -- --
Cost of Revenue $6.0K $1.0K -- -- $1.0K $1.0K -- --
Gross Profit $15K $2.0K -- -- $17K $6.0K -- --
Research & Development $35K $76K $46K $110K $52K $75K $103K -$108K
Selling, General & Admin $156K $167K $1.62M $118K $261K $246K $248K $294K
Total Operating Expenses -- -- -- -- -- -- $1.01M $26.23M
Operating Income -$648K -$702K -$2.29M -$1.17M -$948K -$1.15M -$1.01M -$26.23M
EBITDA -$364K -$418K -$2.00M -$884K -$660K -$865K -$727K -$25.95M
Interest Income $4.0K $2.0K $5.0K -- $3.0K $3.0K $3.0K --
Interest Expense -- -- -- $0 $262K $260K $271K $270K
Income Before Tax -$644K -$700K -$2.28M $2.65M -$1.48M -$14.35M -$1.28M -$27.10M
Net Income -$645K -$699K -$2.29M $5.25M -$1.47M -$14.35M -$1.27M -$27.11M
Basic EPS -$0.08 -$0.13 -$0.26 -- -$1.52 -$15.07 -$1.40 --
Diluted EPS -$0.08 -$0.13 -$0.26 -- -$1.52 -$15.07 -$1.40 --
Basic Shares Outstanding 8.5M 8.4M 8.4M -- 965.6K 954.1K 944.5K --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $3.0K $2.00M $1.0K $2.0K
Cash & Short-Term Investments $3.0K $2.00M $1.0K $2.0K
Accounts Receivable, Net $5.0K $201K $0 --
Inventory $63K -- -- --
Total Current Assets $411K $2.45M $332K $122K
Property, Plant & Equipment, Net -- $17K $287K $276K
Goodwill -- $25.09M $25.09M $25.09M
Intangible Assets $16.99M $17.81M $18.92M $20.03M
Total Non-Current Assets $16.99M $17.84M $44.30M $46.38M
Total Assets $17.41M $20.29M $44.63M $46.50M
Accounts Payable $347K $314K $832K $539K
Other Current Liabilities $621K $399K -- --
Total Current Liabilities $1.16M $9.79M $13.14M $10.59M
Total Non-Current Liabilities $688K $3.27M $3.23M $3.23M
Total Liabilities $1.85M $13.05M $16.37M $13.83M
Common Stock $105K $11K $10K $70K
Retained Earnings -$49.51M -$37.67M -$12.96M -$8.62M
Total Stockholders' Equity $12.31M $4.26M $25.22M $29.56M
Total Equity $15.55M $7.24M $28.26M $32.67M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $21K $10K $20K $3.0K $12K $624K $1.32M $2.00M
Cash & Short-Term Investments $21K $10K $20K $3.0K $12K $624K $1.32M $2.00M
Accounts Receivable, Net -- -- -- $5.0K $15K $200K $4.0K $201K
Inventory $56K $62K $63K $63K $485K $486K $489K --
Total Current Assets $102K $320K $377K $411K $917K $1.48M $2.18M $2.45M
Property, Plant & Equipment, Net -- -- -- -- $13K $14K $16K $17K
Goodwill -- -- -- -- -- -- -- $25.09M
Intangible Assets $16.14M $16.43M $16.71M $16.99M $17.28M $17.57M $17.85M $17.81M
Total Non-Current Assets $16.32M $16.43M $16.71M $16.99M $17.29M $17.58M $17.87M $17.84M
Total Assets $16.43M $16.75M $17.09M $17.41M $18.21M $19.06M $20.05M $20.29M
Accounts Payable $450K $467K $374K $347K $576K $554K $615K $314K
Other Current Liabilities $1.62M $1.33M $1.10M $621K -- -- -- $399K
Total Current Liabilities $2.37M $2.04M $1.69M $1.16M $23.79M $23.17M $9.97M $9.79M
Total Non-Current Liabilities $688K $688K $688K $688K $3.27M $3.27M $3.27M $3.27M
Total Liabilities $3.06M $2.73M $2.38M $1.85M $27.06M $26.44M $13.24M $13.05M
Common Stock $108K $108K $108K $105K $12K $12K $12K $11K
Retained Earnings -$53.14M -$52.49M -$51.79M -$49.51M -$54.75M -$53.28M -$38.94M -$37.67M
Total Stockholders' Equity $10.12M $10.77M $11.46M $12.31M -$11.81M -$10.34M $3.84M $4.26M
Total Equity $13.37M $14.01M $14.71M $15.55M -$8.85M -$7.38M $6.81M $7.24M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$11.87M -$24.77M -$4.41M -$7.25M
Depreciation & Amortization $1.15M $1.12M $1.12M $1.11M
Stock-Based Compensation $13K $19K -- --
Change in Receivables -$1.0K $128K -- --
Change in Inventory $7.0K -- -- --
Change in Payables $470K -$436K $293K $424K
Operating Cash Flow -$1.89M -$2.85M -$2.85M -$2.24M
Investing Cash Flow $3.0K $2.0K -$15K -$349K
Common Stock Issued -- $3.73M -- --
Financing Cash Flow -$109K $4.85M $2.87M $2.55M
Net Change in Cash -$2.00M $2.00M -$1.0K -$44K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$644K -$700K -$2.28M $5.24M -$1.48M -$14.35M -$1.28M -$27.13M
Depreciation & Amortization $284K $284K $285K $286K $288K $288K $283K $279K
Stock-Based Compensation $0 $0 $1.44M $8.0K $1.0K $2.0K $2.0K --
Change in Receivables $0 $0 $5.0K -- -- -- -- --
Change in Payables -$17K $93K $27K $607K $22K -$61K -$98K -$605K
Operating Cash Flow $11K $470K -$464K $99K -$613K -$694K -$682K -$986K
Investing Cash Flow $0 $2.0K -$1.0K $1.0K $1.0K $0 $1.0K --
Financing Cash Flow -- -- $482K -- -- -- -- $317K
Net Change in Cash $11K -$10K $17K -$9.0K -$612K -$694K -$681K -$669K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin -1225.0% -- -- --
Operating Margin -13381.2% -- -- -6808.0%
Net Profit Margin -36993.8% -- -- -14510.0%
Return on Equity (ROE) -96.2% -580.1% -17.2% -24.5%
Return on Assets (ROA) -68.0% -121.8% -9.7% -15.6%
Current Ratio 0.35x 0.25x 0.03x 0.01x
Quick Ratio 0.30x 0.22x 0.00x 0.00x

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) 16.0% 7.3% -112.2% -96.2% -- -- -651.0% -580.2%
Return on Assets (ROA) 9.8% 4.7% -75.3% -68.0% -242.7% -201.9% -124.8% -121.8%
Current Ratio 0.04x 0.16x 0.22x 0.35x 0.04x 0.06x 0.22x 0.25x
Quick Ratio 0.02x 0.13x 0.19x 0.30x 0.02x 0.04x 0.17x 0.22x
Revenue Growth (YoY) +16.7% -57.1% -- -- -- -- -- --
Gross Profit Growth (YoY) -11.8% -66.7% -- -- -- -- -- --
Net Income Growth (YoY) -- -- -- -- -134.6% -- -- --
EPS Growth (YoY) -- -- -- -- -132.2% -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001834105) · from June 30, 2022 Data through September 30, 2026 · synced Nov 21, 2026, 05:00 UTC · Open in terminal